The total number of scientific publications in drug discovery in France is exhibiting a declining trend from 2024 to 2028. In 2023, it stood at a higher level which started to decline with forecasts predicting 138.26 publications in 2024, decreasing steadily to 128.52 by 2028. The average annual decrease over this forecast period is approximately 1.8%. The year-on-year decline suggests a consistent reduction in research activity as compared to previous years, possibly indicating shifting priorities or funding constraints in the sector.
The decline in scientific publications in drug discovery over the next five years may present concerns; however, it could also stimulate innovation in alternative research methodologies. Key future trends to observe include the integration of artificial intelligence and machine learning in drug discovery, shifts in research funding policy, and potential collaborations with international entities to boost scientific output.
